| MR编号 | NL/H/3718/004 |
|---|
| 药品名称 | Sunitinib Teva 50 mg, hard capsules |
|---|
| 活性成分 | |
|---|
| 剂型 | Capsule, hard |
|---|
| 上市许可持有人 | Teva Nederland B.V.
Swensweg 5
2031 GA Haarlem
Netherlands |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Sunitinib Teva 50 mg, hard capsules |
|---|
| 互认成员国 - 产品名称 | - Iceland (IS)
Sunitinib Teva - Germany (DE)
Sunitinib-ratiopharm 50 mg Hartkapseln - Denmark (DK)
Sunitinib Teva - Belgium (BE)
Sunitinib Teva - Luxembourg (LU)
Sunitinib Teva, 50 mg, Gélule - United Kingdom (Northern Ireland) (XI)
- Austria (AT)
Sunitinib Teva 50 mg Hartkapseln - France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
Sunitinib Teva - Finland (FI)
- Poland (PL)
Sunitinib Teva - Latvia (LV)
Sunitinib Teva 50 mg cietās kapsulas - Lithuania (LT)
Sunitinib Teva 50 mg kietosios kapsulės - Estonia (EE)
SUNITINIB TEVA - Hungary (HU)
SUNITINIB TEVA 50 mg kemény kapszula - Bulgaria (BG)
Sunitinib Teva - Czechia (CZ)
Sunitinib Teva - Romania (RO)
- Slovakia (SK)
Sunitinib Teva 50 mg tvrdé kapsuly - Slovenia (SI)
Sunitinib Teva 50 mg trde kapsule - Croatia (HR)
Sunitinib Pliva 50 mg tvrde kapsule
|
|---|
| 许可日期 | 2018/01/10 |
|---|
| 最近更新日期 | 2024/07/24 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|